Literature DB >> 8631883

Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.

J X Lin1, J Mietz, W S Modi, S John, W J Leonard.   

Abstract

We have isolated a second human Stat5 cDNA, Stat5B, and demonstrated that the genes encoding both Stat5A and Stat5B are located at chromosome 17q11.2. Both genes were constitutively transcribed in peripheral blood lymphocytes. By using specific antisera, we demonstrated that both Stat5A and Stat5B are activated by interleukin-2 (IL-2) in peripheral blood lymphocytes, natural killer-like YT leukemia cells, and human T cell lymphotropic virus type I-transformed MT-2 T cells. In COS-7 cells, which constitutively express the Janus family tyrosine kinase Jak1, reconstitution of IL-2-induced Stat5A and Stat5B DNA binding activities was dependent on the coexpression of Jak3 along with the IL-2 receptor beta chain and the common cytokine receptor gamma-chain. This IL-2-induced Stat5 activation was dependent on the presence of either of two tyrosines (Tyr-392 or Tyr-510) in the IL-2 receptor beta chain, indicating that either of these two tyrosines can serve as a docking site. Moreover, we demonstrated that human Stat5 activation is also dependent on Tyr-694 in Stat5A and Tyr-699 in Stat5B, indicating that these tyrosines are required for dimerization. The COS-7 reconstitution system described herein provides a valuable assay for further elucidation of the IL-2-activated JAK-STAT pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631883

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Authors:  E Soldaini; S John; S Moro; J Bollenbacher; U Schindler; W J Leonard
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 3.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 4.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

5.  STAT5A encoding gene maps to chromosome 19 in cattle and goat and to chromosome 11 in sheep.

Authors:  T Goldammer; L Meyer; H M Seyfert; R M Brunner; M Schwerin
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

6.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

7.  Rapid STAT phosphorylation via the B cell receptor. Modulatory role of CD19.

Authors:  L Su; R C Rickert; M David
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

8.  The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities.

Authors:  Xavier Espanel; Martine Huguenin-Reggiani; Rob Hooft van Huijsduijnen
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

9.  S731 in the transactivation domain modulates STAT5b activity.

Authors:  Amanda M Weaver; Corinne M Silva
Journal:  Biochem Biophys Res Commun       Date:  2007-08-28       Impact factor: 3.575

10.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.